Relay Therapeutics has a promising 4D drug design platform but faces challenges with limited clinical data and high R&D expenses. Despite a strong IPO and substantial cash reserves, the stock has ...

Belite Bio's lead drug, Tinlarebant, targets eye diseases STGD1 and GA, showing promising results but with delayed phase 3 trial data expected by late 2024 or early 2025. Tinlarebant works by reducing ...

These scientists may be lesser known than Einstein and Newton, but they made giant contributions to science, including astronomy, physics, chemistry and medicine. When you purchase through links on ...

Talk about a bizarre feature of the human body: If you happened to swallow a razor blade, your stomach acid would dissolve it. Acids are ranked on a scale from zero to 14—the lower the pH level, the ...

Launched in December 2021 after three decades of development and at a cost of some $10 billion, NASA’s James Webb Space Telescope (JWST) is one of the biggest investments ever made in astronomy. That ...